Skip to main content
OpenTrials
Completed

NCT Number: NCT06131853

Kinesiophobia in Prostate Cancer

This study aimed to investigate the effects of prostate cancer on patients' physical activity, kinesiophobia, fatigue and functionality.

This research is a prospective study to be conducted on volunteer individuals between the ages of 40-75. People diagnosed with prostate cancer (study group) and healthy adults who have not been diagnosed with prostate cancer before (control group) will be included in the study. The demographic characteristics, physical activity levels and quality of life of all individuals participating in the study will be evaluated with an online form. In demographic data, physical, sociodemographic data such as age (years), height (cm), body weight (kg), body mass index (kg/m2) and disease-specific information will be recorded. Physical activity level will be measured with the International Physical Activity Survey short form (UFAA), fatigue with the Functional Evaluation of Chronic Disease Treatment-Fatigue Questionnaire, fear of movement with the Causes of Fear of Movement Questionnaire, and quality of life with the Functional Evaluation of Cancer Treatment-Prostate Version questionnaire (KHTFD-Y).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (for prostate cancer-study group)
  • Being between the ages of 40-75
  • Want to participate in the study
  • Being able to read and write
  • Being diagnosed with prostate cancer by a specialist physician,
  • Being able to provide their mobility independently,
  • (for healthy controls - control group)
  • Being between the ages of 40-75
  • Not having any previous cancer history and not having undergone cancer surgery
  • Volunteering to participate in the study

Exclusion criteria

  • Those with a previously known or accompanying diagnosis of dementia
  • Not wanting to participate in the study
  • The individual has a disease that may prevent him or her from understanding and completing the survey.
  • Illiterates
  • Those who do not want to participate in the research voluntarily
  • Having active metastasis
  • Having undergone chemotherapy and radiotherapy in the last 6 months

Treatment and study plan

survey evaluation

Other

assessment of physical activity, fatigue, fear of movement, and quality of life

Primary outcomes

  1. International Physical Activity Survey short form

    Time frame: 10 minutes

    The short form consists of 7 questions. The form provides information about the frequency and time spent in walking, moderate physical activity, and vigorous physical activity.

  2. Functional Assessment of Fatigue Chronic Disease Treatment-Fatigue Questionnaire

    Time frame: 10 minutes

    It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.

  3. Reasons for Fear of Movement Questionnaire

    Time frame: 10 minutes

    It allows the causes of kinesiophobia to be identified and both biological and psychological causes to be determined separately. The average of the scores obtained from the biological and physiological subscales gives the total score from the survey. A 5-point Likert scoring (1 = Totally disagree, 5 = Completely agree) is used in the scale. An individual's high score from the survey indicates that he/she has more fear of movement.

  4. Functional Evaluation of Cancer Treatment-Prostate Version questionnaire

    Time frame: 10 minutes

    It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.

Sponsors and collaborators

Lead sponsor

Selcuk University

Other

Registry information

Official study title

Physical Activity, Fear of Falling, Fatigue and Functionality in Prostate Cancer

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Nov 14, 2023
Registry last updated
Jan 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.